Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype

Cardiovascular disease in polycystic ovary syndrome*

(2013) S. L. Atkin   CLINICAL ENDOCRINOLOGY

The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome

(2012) Carolina Sales Vieira et al.   CONTRACEPTION

Adipocytokine profiles in a putative novel postmenopausal polycystic ovary syndrome (PCOS) phenotype parallel those in premenopausal PCOS: the Rancho Bernardo Study

(2012) Andrew J. Krentz et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Inflammation and large arteries: Potential mechanisms for inflammation-induced arterial stiffness

(2012) Kaisa M. Mäki-Petäjä et al.   Artery Research

Recently postmenopausal women have the same prevalence of subclinical carotid atherosclerosis as age and traditional risk factor matched men

(2011) Kimon S. Stamatelopoulos et al.   ATHEROSCLEROSIS

Ovarian Hypertension: Polycystic Ovary Syndrome

(2011) Rhonda Bentley-Lewis et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

MECHANISMS IN ENDOCRINOLOGY: Recent advances in cardiovascular aspects of polycystic ovary syndrome

(2011) T Sathyapalan et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

(2011) Bart C.J.M. Fauser et al.   FERTILITY AND STERILITY

Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis

(2011) Michelle L. Meyer et al.   HUMAN REPRODUCTION UPDATE

Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women

(2011) Maria Creatsa et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome

(2011) L. F. N. Zueff et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis

(2010) Héctor F. Escobar-Morreale et al.   FERTILITY AND STERILITY

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

(2010) Robert A. Wild et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Hyperandrogenism in Women with Polycystic Ovary Syndrome Persists after Menopause

(2010) Marios C. Markopoulos et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome

(2010) Irene Lambrinoudaki   MATURITAS

The role of low-grade inflammation in the polycystic ovary syndrome

(2010) Andrea Repaci et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Dissociation of endothelial function and arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS)

(2009) Andrea J. Cussons et al.   CLINICAL ENDOCRINOLOGY

Metformin Reduces Arterial Stiffness and Improves Endothelial Function in Young Women with Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled, Crossover Trial

(2009) Neera Agarwal et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

How steroid hormones act on the endothelium—insights by atomic force microscopy

(2008) Uta Hillebrand et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY